Khurram Nasir
@khurramn1
Followers
7,101
Following
3,479
Media
1,291
Statuses
19,648
Husband, Father/ Preventive Cardiologist/Health Policy/ Social Justice & Health Equity/Big Data Applications
Houston Methodist DeBakey, COR
Joined November 2013
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Eigen
• 879812 Tweets
Wasit
• 268611 Tweets
Scotland
• 132130 Tweets
Uzbek
• 102983 Tweets
#HappyBirthdayRohit
• 99212 Tweets
Mufasa
• 67497 Tweets
Jerome
• 65101 Tweets
#محمد_بن_سلمان
• 63747 Tweets
billie
• 46276 Tweets
Madonna
• 43372 Tweets
ARMY ARE FOREVER BEHIND BTS
• 43276 Tweets
Rock in Rio
• 30600 Tweets
Seinfeld
• 29287 Tweets
Nadal
• 25816 Tweets
HBD PP KRIT 25th
• 21231 Tweets
Medina
• 20484 Tweets
gracie
• 17427 Tweets
Tekno
• 14208 Tweets
Jake Paul
• 13839 Tweets
Fermin
• 12960 Tweets
Humbly honored for this recognition today
Thank you,
@Heart_SCCT
and especially my friends
@RonBlankstein
@Agatston_Center
presenting it, made it more special
Truly proud to be among the pantheon of cardiology giants who were previously recognized.
34
30
213
This is our senate🤦
Sen. Ron Johnson (R-WI) is claiming the CDC & bureaucrats are "scaremongering" so that people won't use hydroxychloroquine.
1K
179
630
46
34
198
#1
Dreams do come true, needed a spark in 2014, health system
@BaptistHealthSF
inspired to make difference, bold leadership (
@JackZiffer
@DrBTKatzen
@Calvinchb
@drjbone1
& others), generous community coming together
#MiamiHeartStudy
to realize the first fruit of these efforts👇
33
48
206
True 👇
I agree people are fed up, but covid won’t end until the world’s low income countries get vaccinated to prevent new variants. Our failure to vaccinate enabled delta-India, omicron-Africa. More to come unless we vaccinate globally. Our
@TexasChildrens
vaccine is essential for this
279
886
4K
4
31
159
18
8
124
Pleased to announce 1-year subspecialty training in clinical preventive cardiology
@HMethodistCV
with tremendous research opportunities
Eligible after completion of IM or cardiology training
Starting July 2021
Those interested, email me directly
Details👇
@SLittleMD
9
27
120
Are u looking for postdoctoral position regarding CVD prevention, athero imaging, big data, SDOH & related policy implications?
DM knasir
@houstonmethodist
.org
Candidate with MD, MPH and/or background in data analytics preferred
@JohnsHopkinsSPH
@HarvardChanSPH
@EmoryRollins
10
42
111
#PowerOfZero
finally embraced by chol guidelines for statin decisions. 7.5-20% risk & CAC=0-> OK TO AVOID STATIN (IIA)
#AHA18
What took so long? What were major milestones-> got us here?
@rblument1
@MichaelJBlaha
@hmkyale
@RonBlankstein
@ErinMichos
@MBittencourtMD
@DrMarthaGulati
6
50
106
Great podcast
So much more to learn
Episode today on
#LongCovid
. Virologist
@angie_rasmussen
& ER doc/EBOLA patient
@Craig_A_Spencer
.
Listen to what we know. It’s time to recognize people & invest in learning more now.
24
187
501
1
17
104
@MaBMortensen
asks a critical question
Should we consider all with elevated LDL at the same risk? Does everyone need to be treated similarly?
Judge for yourself
I hope in the era of precision we are not reverting back to law of averages
@miguelcainzos23
11
25
103
Cannot be more proud & happier for my dear friend
@MichaelJBlaha
honored with Arthur Agatston Award at
#SCCT2022
changing how we view CAC
#PowerOfZero
for primary prevention for ever
Congrats & nobody deserves it more!
@rblument1
@CiccaroneCenter
@HopkinsMedicine
@Agatston_Center
5
17
102
We need more PD like
@MarkDSiegel1
who has the foresight and celebrates the diversity of experiences/passion/productivity of highly motivated
#IMG
contributing to success of respective institutions and healthcare in US in general. Kudos👏👏
@YaleMed
@MethodistHosp
@HMinternalmed
Starting 2023 with another powerful PD note by
@MarkDSiegel1
celebrating open doors, diversity, and opportunities for all!
"Since 2011, the year I became PD, we’ve matched IMGs from 🇮🇳🇮🇷🇮🇱🇸🇦🇹🇷🇬🇷🇮🇹🇦🇹🇩🇪🇩🇰🇷🇺🇨🇴🇵🇪🇧🇷🇲🇽🇨🇦. This year, we’re trying for more."
👉
8
38
219
3
20
96
1 of best written editorial from maestro
@RonBlankstein
#Chandrashekhar
@JACCJournals
read in recent yrs
a guide how to approach complex issues accounting uncertainties/data vs limiting to mere soundbites
using example
"CAC in Symptomatic pts: Can Data Settle the Debate?"👇
5
25
97
Heartiest congrats to my mentor, advisor, and most importantly friend
@hmkyale
Among innumerable achievements, thanks for teaching us art of asking the right questions, pursing academic endeavors from patients perspective...the world is a much better place because of you🙏
9
16
96
We now can test for antibodies to determine whether had COVID19
Dr Fauci-> individuals 'really protected from reinfection'
Can (should) we consider testing this in HCW->+ve theoretically less risk->can be more involved at frontline with active cases?
Asking for ur opinion🙏
15
9
92
#1
Assessing comprehensive cardiovascular screening among men 1400 65 to 74 years of age in Denmark to assess in improved outcomes, cost effective approach from a societal perspective
See Summary below, though deeper dive needed
7
30
91
61% Clinical FH patients with CAC Zero!
Mean age 56
Loved the discussion
#PowerOfZero
getting more acceptance.
#FactsAreFacts
13
17
89
#1
Thanks
@WilliamZoghbi
for the announcement. Bittersweet moment, at the same very excited about transition to
@HMethodistCV
seeking to align precision medicine and population health approaches with a singular focus “Cardiovascular Disease Prevention & CV Health Promotion ”
It is official! Happy to announce that Dr Khurram Nasir of Yale, will be joining us
@HMethodistCV
as Director of CV Wellness & Prevention and Co-Director of the Center of Outcomes Research, bringing Expertise in prevention, population health & health economics. Welcome Khurram!
31
13
146
19
8
89
Delighted to see our view working with
@miguelcainzos23
on the evolution of CAC testing our time, its prime time application and future directions
Still lot to do, but definitely has transformed and continue to impact CV prevention across the globe
4
24
88
Daily low-dose aspirin no longer recommended as heart attack preventative for older adults
3
37
84
Excited for
#ACC24
?
Visit
@NasirLab_HM
@HMethodistCV
prevention team presentations & share ur feedback
-Burden, variability and national/health system impact of CV metabolic risk
-CV impact of exposome measurements
- Insights on Cardiorhum & novel atheromeasurement in gen pop
6
16
84
Looking for a motivated postdoc to join our team participating in exciting projects related to CVD health system big data & pop health, pharmacoeconomics, health policy/SDOH & outcomes)
MPH & strong analytic background preferred
If interested DM at knasir
@houstonmethodist
.org
4
23
83
Friends.. pt 59 yr female with LDL >300 as long as she knows
Healthy
never statin or Other lipid lowering
Cac zero 😳
Not interested in treatment at all for now..
Perplexed..
Next steps? CCTA?
@rblument1
@DrMichaelShapir
@rauldsf_santos
@virani_md
@pnatarajanmd
44
14
80
Tremendous burden premature CVD in
#Pakistan
, not waiting for others to solve problems ,
#BashirHanif
leading landmark prospective study->addressing national CVD & atherosclerotic dis burden w local/international/industry collaboration
Join us to maximize success
@miguelcainzos23
15
20
81
Humbly honored for this recognition today
Thank you,
@Heart_SCCT
and especially my friends
@RonBlankstein
@Agatston_Center
presenting it, made it more special
Truly proud to be among the pantheon of cardiology giants who were previously recognized.
14
7
79
#1
Health disparities form along several societal fault lines
Among others quite clear that your zip code may hold more sway that your generic code in US
In our daily practice we clearly see Belmar Divide playing out in our own backyards
Why important from CVD perspective? 👇
2
22
75
@ashishkjha
Exactly
even if the "mortality rate" not high or falling, with greater cases (denominator), actual "deaths" (one metrics that matters) will be high
Why this is hard to apprehend?
4
5
69
So proud of
@PSatishMD
amazing 3 yr tenure as
@HMHCardioFellow
now ready to lead
#CvPrevention
program in
#Austin
with a focus towards promoting
#SouthAsiansCvHealth
Great advice on clinical program implementation, hoping to create collaborative community around it
👏👏
8
11
70
Excellent summary of top 10 papers in cardiac Ct last yr by
@ToddVillinesMD
@Heart_SCCT
#SCCT2022
@RonBlankstein
@MichaelJBlaha
@miguelcainzos23
@JonFialkowMD
@rblument1
@BaptistHealthSF
@HMethodistCV
1
14
70
#1
ACC/AHA guidelines suggest no further risk stratification among LDL>190 mg/dl (severe hypercholesteremia).
Many wary of
#PowerOfZero
to
#Derisk
Learn potential role of CAC testing in this highrisk group from MESA addressing these knowledge gaps👇
4
25
70
unfortunate, issue of IMG not on radar for D&I champions
especially true for top programs->most hospitalist r IMG, but hardly any in training program
Message: good enough to take care of pts, not good enough to train?
@DrMarthaGulati
@AnkurKalraMD
@JavedButler1
@GarimaVSharmaMD
Emailed program about IMG criteria for app. They felt the need to say: they rarely interview IMGs. It’s hard for me to understand how programs claim to “Promote a culture of diversity”, when they limit population to a small bubble.🤷🏻♀️ Thanks for being honest I guess?
#medtwitter
82
90
910
12
9
68
@BudoffMd
highlights
-benefit of "purified high dose EPA" vs generic or combo fish oils (EPA/DHA)
-benefits of EPA even in primary prevention (JELIS)
-In REDUCE IT higher benefit with higher EPA achieved
-EVAPORATE showed EPA benefit on plaque regression/stabilization
@DLBHATTMD
1
27
65
With 5 days to Chol management guidelines update
@AHAMeetings
..gentle reminder in
@JACCJournals
: It’s time to accept the
#PowerOfZero
.
Hope it’s not too late!
@rblument1
@hmkyale
@MichaelJBlaha
@RonBlankstein
@ErinMichos
@MBittencourtMD
.
Some thoughts👇
3
36
64
"In borderline/intermediate ASCVD risk, CAC should be used, WHENEVER POSSIBLE, as aid to rational statin allocation for primary prev ASCVD"
"in absence of CAC, odds of misclassifying borderline/intermediate-risk pt 10year risk similar to of a coin flip"
3
21
63
Controversial ongoing discourse
Are all heterozygous FH the same?
Can we expect CAC zero?
Is it associated with low risk?
Study from Japan
@ESC_Journals
622 HeFH pts, baseline LDL>200
45% CAC=0
10+ yr FU->mere 1.2/1000 CVD event person yr
Need more reassurance? Need PCSK9i?
5
15
63
“It’s academics baby” 🤦
First we need to change the reward system focusing on publications alone vs impact
Second we need to collectively stop publishing in journals with high open access fee (guilty myself)
#preprints
@medrxivpreprint
@hmkyale
3
6
62
Surprised?
@rauldsf_santos
@MichaelJBlaha
@rblument1
@RonBlankstein
@DrMichaelShapir
@DrMarthaGulati
#EASCongress2023
13
6
63
What did I learn today?
-Many Monday am quarterbacks on
#medtwitter
- will always provide advice on how to conduct a study with doing one
In the interim my advice to “doers”
progress is progress.. keep pushing!
3
5
62
Thoughtful editorial by
@AnnMarieNavar
et al on our recent paper led by
@miguelcainzos23
asking
"Is CAC Scanning the 'Secret Sauce' for Affordable ASCVD Primary Prevention Trials?"
We believe the answer is YES!
Completely agree with ur suggested approach for future trials👇
1
16
61
honored to co-host
@DrMarthaGulati
@AnumSaeedMD
@virani_md
@DrMichaelShapir
for small breakout discussion on preventive cardiology🙏
Subspecialty still in infancy & remains fragmented from standard of care services as well as education and training
Need more formal structure
4
16
61
A well-deserved congrats
@hmkyale
🥂
Massive applause on becoming
#JACC
Editor-in-Chief
With exceptional contributions to education, research, and patient care, along with knack for knowing where the puck is going to be, make you the perfect captain steering JACC to new heights!
1
3
61
With emerging novel therapies beyond statins and ASA (PCSK9i, GLP-RA1, SGLt2 antagonists, Purified EPA etc) how best to enrich RCT for efficient study design?
@miguelcainzos23
and his team has some suggestions
@ProfKausikRay
@DLBHATTMD
2
11
58
#1
While as preventive cardiologist we all organize information from imaging and biomarkers in a debate with my dear friend
@CBallantyneMD
, asked tough Q what would I choose if I had one option?
The answer is clear and maybe not debatable anymore
@ASPCardio
@Heart_SCCT
7
27
58
@DBelardoMD
keeping it simple
-Diet key for 4 big CV RF management: hyperlipidemia, DM, HTN, obesity
-Detail nutrition assessment key
-Irrespective diet preferences, basic strategies for all->Avoid snacking, lower liquid calories/alcohol
-Increase fiber intake
#DeBakeyPrevention
3
20
56
What happens if your have significantly elevated LDL...Does everyone have CAC or plaque?
Learn more from
@WofaKay_Hagan
@HMethodistMD
from the
#MiHeart
@BaptistHealthSF
Mod poster 4 12:40 pm today
Conclusion:Many have no disease, no surprise!
#AHA22
1
20
56
#1
Great report by
@AvinainderSingh
@RonBlankstein
on High prevalence of clinically defined FH phenotype in young presenting with AMI
2
21
56
What a delight to see my dear friend & Digital health guru
@ahmsolmd
, pride of
@HMethodistCV
, to receive the prestigious "Physician of the Year Award" 👏👏 from
@WilliamZoghbi
Keep shining even more brightly & inspiring us all!
14
4
57
Practical tips by
@MichaelJBlaha
on managing cardiometabolic risk among T2DM
-Careful evaluation of goals, side effects, and pt consideration
-Prefer SGLT2i (HF) or GLP1-RA (ASCVD) risk predominate
-Starting GLP1-RA, adjust other DM meds, start low, go slow
#DeBakeyPrevention
2
24
57
wonderful to learn
@AKUAANA
@SKhanMHCM
leading amazing initiatives bringing much needed healthcare facilities in
#Quetta
, performed the first TAVI at
#NICVD
, imparting leadership skills among
@AKUGlobal
med students...and much more... A true national treasure!
@ZainabASamad
6
3
56
Does elevated Lp(a) increase future risk of ascvd if cac zero?
Answer:no
Hard to beat
#PowerOfZero
@hmkyale
@dramitkhera
@DrPJoshi
@rblument1
@RonBlankstein
@DrMichaelShapir
@MichaelJBlaha
Our moderated poster for
#ACC20
evaluating the independent and additive prediction of ASCVD by Lp(a) and CAC: - link for audio
@ACCinTouch
@ACCmediacenter
@amehta_09
@dramitkhera
@DrPJoshi
@UTSWIMchief
@UTSWCardfellow
6
6
38
4
18
55
# 1 While the
#PowerOfZero
has a well established role to guide management for asymptomatic individuals, despite strong data there has been 'controversy' as well as resistance to consider its role as
#gatekeeper
in symptomatic patients...we have been making a case for it
5
12
55
@drpablocorral
@eatthesunnow
#Exhibit
1
- Huge heterogeneity in dyslipidemia/LDL levels and CAC presence and burden
- Once’s risk is truly determined (mainly) by CAC burden when compared to LDL levels
As you can see even minimal CAC in lower LDL is higher risk than CAC zero in highest LDL
2
10
53
Humbling. Very hard to put ourself in the patient’s shoes, but at least we can try. A note worth reading everyday to remind ourself of immense privilege, that’s also comes with great responsibility, in caring for those when most vulnerable.
@YaleCardiology
@YaleMedicine
2
24
51
If you 1 hour to spend, read this paper by
@MichaelJBlaha
et al 👏👏
All you need to know how
#MESA
laying the groundwork for future of CVD risk assessment & management in primary prevention
Journey from RF based approach to disease detection👇
4
13
52
Pleasure to host dear friends, lot discussed around healthcare in Pakistan (
@SKhanMHCM
leading in
#Quetta
), making CV prevention viable financial model (
@WilliamZoghbi
@DrMarthaGulati
), impact shifting young gen priority 'publication' vs 'investigation'
Need to meet more often
Saturday night hangout in Houston with my favorite people
@khurramn1
@virani_md
. We need more investigators than prolific publishers. Pick one area of interest and go deep. Many pearls of wisdom learned.
9
5
134
6
5
51
🥂to
@DrMarthaGulati
, recipient of prestigious
#ArthurAgatstonAward
, for her tireless dedication & unwavering commitment improving
#WomenHeartHealth
#CVDprevention
Well-deserved recognition for the profound impact on countless lives including many mentees.
Truly inspiring !!
Congratulations to the
#SCCT2023
Agatston Award recipient,
@DrMarthaGulati
. This award recognizes individuals whose pioneering efforts have saved lives from the leading killer throughout the world, coronary artery disease.
52
37
216
1
4
51
While there is so much established about CAC..
for
@Heart_SCCT
Prevention Symposium, I was asked by
@RonBlankstein
to talk about
"what's next for CAC Testing in 2021 (and beyond)?"
What are the main applications in the future?
@miguelcainzos23
@jaideeppatelmd
3
18
50
@DrMarthaGulati
highlighting CVD differences from the sex and gender perspectives for the 🇵🇰 community at pak card society
#CardioCon
You have u present live in 🇵🇰 next time
@ZainabASamad
@ditchhaporia
@GarimaVSharmaMD
@WilliamZoghbi
4
7
49
Important message👇
Once established ASCVD,
#statin
adherence key for better outcomes
Need stronger efforts to ensure higher continuation rates in this high risk group
@ASPCardio
@CardioNerds
@CiccaroneCenter
@HMHCardioFellow
@ACCinTouch
@AHAScience
@society_eas
@rauldsf_santos
2
9
49
Big debate tomorrow..trying to convince a hard audience
#SCCT2022
"
#PowerOfZero
is all you need for risk stratification"
Agree hard to beat it!
But what to summarize in 7 minutes? Any suggestions? What would you like to hear?
@miguelcainzos23
@cardioQT
@AChoiHeart
@rblument1
6
18
49
Well-deserved recognition of
@RonBlankstein
immense contributions to academic medicine, in all its realms of education, research & patient care
Greatest personal joy witnessing from the front seat his pragmatic leadership, generosity, wise counsel & most importantly, friendship👏
Huge congratulations to long-time friend Dr. Ron Blankstein (far right) on his recent promotion to Full Professor at Harvard Medical School! Ron has been an amazing proponent of Preventive Cardiology & judicious use of imaging in CV management. Here is a great photo from ASPC19!
37
22
231
5
3
49
After reading this just came to conclusion.. get rid of Personal statement..totally useless. We r looking for great physicians, humanists, possibly curious scientists, why emphasis on how able to narrate a unique experience (such as baking cake) that captures one’s interest🤔
Take home points:
1. Use one of the recipes if you want to write a safe, boring PS.
2. Compelling PSs are narrative stories that provide insights to you as a person that is unavailable otherwise.
3. Want to write well? Read good writers. I put three in the tweets above.
FIN/
37
50
416
5
5
48
Social inequities (
#SDOH
) among cardiometabolic disease pt real, grateful to wonderful team's publication in last month highlighting challenges 👇
Time to broaden focus of SDOH measures to include
#Transportation
#FoodInsecurity
#FinancialToxicity
& aggregated
#PolysocialRisk
2
10
49
Hostile work environment in cardiology?
Nearly 1 in 2 cardiologist reporting it
67% women & 37% males suffering from discrimination, emotional & sexual harassment
@ACCinTouch
Lets fix our own house, can't ignore anymore
🙏
@GarimaVSharmaMD
@DrLaxmiMehta
2
13
49
Well said👇
The best cure for loneliness is not more frequent interaction. It's more meaningful interaction.
Many people enjoy solitude. They can spend up to ~75% of their time alone without feeling isolated.
What matters most for well-being is the quality of connections, not the quantity.
220
4K
16K
3
5
48
Had a lot of fun writing this piece with friends
@MBittencourtMD
@almallahmo
@rauldsf_santos
I think the title says it all
#PowerOfZero
passing all hurdles with flying colors
3
13
47
Reflecting down memory lane
An idea with
#AndrewDefilippis
@MichaelJBlaha
on "How can we understand MI better"
Journey started on white board 4 yrs ago
#ACC2019
->months of work->RO1->now methods paper->so much to do!
Power of friendship & asking right Q!
0
12
47
While
#PowerOfZero
well accepted by preventive guidelines in management of asymptomatic pts
We try to nudge the upcoming chest pain guidelines to at least “acknowledge” (path to eventual acceptance)
#PowerOfZero
for Low-Intermediate risk CP pts
4
13
47
Excellent work by
@sdslavin
@haiderwarraich
illuminating that
#financialtoxicity
is not merely a ‘slogan’ but affects millions of pts with CVD and their families and no longer can be ignore
Systematic efforts needed to mitigate these unintended side effects
3
8
47
excellent talk by
@RonBlankstein
at
@MyASNC
#ASNC2020
on very high CAC in asymptomatic
-very high mortality/yr risk (2% all cause and 1% CVD)
-Need very aggressive treatment (CVD equivalent)
-1 in 7 will have ischemia, prefer
#PET
, assess CFR, not to ignore balanced ischemia
5
16
47
Looking forward to discussing
#CoronaryAtherosclerosis
Imaging
#CAC
-> guiding CVD risk management in Pakistan today at
@AKUGlobal
Do we need it?
How much is burden?
CAC vs statin cost?
Non calcified Plaque?
Implications of RF vs disease detection ?
@ZainabASamad
@JamalRanaMD
5
6
46
such wonderful news from
@ASPCardio
This award is just saying "thank you" to
@rblument1
lifelong and selfless ongoing commitment to mentoring countless young physical scientists in this field…
Combined impact of his direct and indirect contributions are unmeasurable🙏
4
11
46
Let me add another category often overlooked due to commonly held misperceptions
IMG
#MissedOpportunities
@AnkurKalraMD
@GarimaVSharmaMD
@safinmc
@ShahzebKhanMD
2
10
46
Good times👇
Looking forward to catching with friends
@ACCinTouch
#ACC22
@ToddVillinesMD
@RonBlankstein
@MichaelJBlaha
@DrMichaelShapir
@GarimaVSharmaMD
@rblument1
@DrMarthaGulati
@lesleejshaw
@BudoffMd
Can’t wait 🙂
What a terrific debate between
@khurramn1
and Todd Villines on CAC vs. CTA!
#SCCTWinter2020
Todd:
#CTAisEasySafe
Khurram: The puck is moving towards value based care --
#WeCanDoBetter
1
7
29
5
1
45
#medtwitter
if anyone know of a Biomarker that predicts cvd event better than cac.. please do let us know..been searching for a while
11
10
44
the most interesting disclosure in my 19 years of publishing..
@michael23ca
and I declare "Dr Nasir and Dr Cainzos-Achirica declare that they are both non-US-born immigrants." 🙂
7
3
45
Tour de Force by
@GarimaVSharmaMD
@kevagargmd
@CiccaroneCenter
on
Complex challenges of sex differences in coronary atherosclerosis
Amazing opportunities to dive deeper & clarify with
#CCTA
#Multimodality
approach->overcome fallacies of "one size fit all"
3
16
44
Want to know about CAC testing? All you need is this review 👇
Our new Coronary Artery Calcium Review Article now online at Heart, which includes a CAC score based treatment algorithm.
@MichaelJBlaha
@CiccaroneCenter
9
68
151
0
8
44
Delighted that
#MiamiHeartStudy
@BaptistHealthSF
could contribute to this critical issue. Next step is prospective follow up for changes.
@JonFialkowMD
🚨🚨🚨🚨🚨🚨🚨🚨
BREAKING:
@BudoffMd
has now presented the matched analysis for:
KETO (
#LMHRstudy
) vs Control (
#MiHeart
)
-🙏Please RT🙏-
METHODS – 80 Participants of
#LMHRstudy
fell within
#MiHeart
age range and were then matched 1:1 for age, gender, race, diabetes mellitus,…
125
601
2K
3
10
45
Do you perceive having good-excellent health? How much subclinical CVD (CAC?) do you have. How would u do in the next 10 yrs?
See interplay published
@JAMANetworkOpen
by led by Olusola A. Orimoloye
@MichaelJBlaha
@RonBlankstein
@mdmiedema
@almallahmo
2
15
44
Exploring
#CardioRheum
with
@Bweber04
🩺 Unveiling Inflammatory Conditions & CV Risk Pathways
🚀
#RiskEnhancers
fueling accelerated atherosclerosis
🔍 Imaging: New Frontier for Early Disease Detection
#SeeDiseaseTreatDisease
@RonBlankstein
#CardiovascularHealth
#CuttingEdge
0
12
43
🌟
@purviparwani
urges cardiologists to embrace "stress management" in CV prevention toolbox
🔍 Begin with assessment
🧘♂️ Explore the power of Yoga
🧘♀️ Discover the benefits of meditation
🏥 Integrate stress management into routine clinical practice
@Heart_SCCT
#SCCTCVPrev
1
15
43
Excellent work led by superstars
@SaurabhSDani
&
@safinmc
leading way on illuminating trends, burden and healthcare implications of growing premature CVD burden
in this specific study focusing on CABG among the young..much more to learn!
👏👏
1
9
43
Wonderful
@AHAMeetings
contributions by
#CvdPrevention
team
@HMethodistCV
& Collaborations with partners
@GarimaVSharmaMD
@Sadeer_AlKindi
@CiccaroneCenter
@AnkurKalraMD
and others
Look forward to these presentations and seeing everyone in person next yr
@miguelcainzos23
3
8
43
So true.. I counsel many aspiring physician scientists on this concept
Great visualization
3
3
42
Practical tips for building and growing cv prevention program
All packed in half day session
Both in person and virtual options 👇
@HMethodistMD
@NYUCVDPrevent
@CiccaroneCenter
@CardioNerds
@atherosociety
@AKUGlobal
@ASPCardio
@Heart_SCCT
@VietHeartPA
@SABOURETCardio
@pabeda1
Need
#CME
and
#CNE
? Don't miss this year's
#CVDPrevention2022
on Oct. 8 featuring Andrew DeFilippis, MD as he presents "
#Thrombotic
Balance: Underappreciated Markers for
#ASCVD
Risk!" REGISTER TODAY at .
@khurramn1
@ASPCardio
#CardioEd
#CardioTwitter
#CVD
0
4
6
1
10
42
Hard to belief that beyond planning, we successfully enrolled 2500 individuals. Kudos to team…best part making so many friends including
@jvaleromd
@ehianeni
@VicOkunrintemi
@gowthyharsha
@DixithaAnugula
@drjbone1
in this journey
So much meaningful scholarship to come from it
Coronary CTA and CAC results in the Miami Heart Study (N=2,500) now available on demand at AHA Scientific Sessions 2021
Saturday Nov 13, 8am to 5pm EST
@khurramn1
presenting the main results on behalf of the study team
#AHA21
#DeBakey
#CVDPrevention
0
11
60
4
9
41
Absolutely
Is your CAC (Coronary Artery Calcium) score more important than your cholesterol levels?
I bet
@realDaveFeldman
has an opinion!
#ketodiet
#cholesterolcode
#carnivorediet
#ketovorediet
21
2
46
7
5
42
Delighted to hear about 2 top fellowship drafts
@safinmc
@VicOkunrintemi
joining
@HMethodistCV
for their cardiology training
Eager to learn from their fresh eyes and optimism about what the future holds for CVD medicine
Welcome to
#Houston
&
@HMethodistMD
@HMHCardioFellow
3
0
41
@DrMarthaGulati
@WilliamZoghbi
@YouTube
@ASE360
@Heart_SCCT
@MyASNC
@SCMRorg
@ACCinTouch
@RonBlankstein
@MethodistHosp
Its been the biggest honor of my life to have witnessed this journey so closely.
wouldn't have been possible without the "team" (and others) that got CAC testing where it is today👇🙏🙏
still lot of work to be done...will need all the help!
#PowerOfZero
4
12
41
Basically what I’m hearing that treating almost anyone with Semaglutide, not necessarily weight reduction, can lower CV risk by multiple pathways 👏
What is needed is to find out who are the ones who are truly going to benefit the most versus the least
@MichaelJBlaha
@ASPCardio
SELECT “establishes overweight and obesity as a modifiable risk factor for cardiovascular disease” -AM Lincoff 🔥
@NEJM
#AHA23
@AHAScience
0
43
169
1
4
39
While healthcare Pakistan remains deeply contested affair with high NCD burden, poverty, access & quality of care issues
Time to look forward with
@Jhagra
developing
@PICMTI_OFFICIAL
capacity to lead CVD prevention/big data/policy leveraging KP universal health coverage programs
6
2
39
Any surprises?
#PowerOfZero
passes another test👇
🔍 Insights from Western Denmark Heart Registry reveal a nuanced impact of LDL-C based on atherosclerosis presence.
🫀Among 23,132 CCTA patients, LDL-C lacks predictive power for future CVD when CAC=0, but strongly correlates with events in CAC>0 cases.
14
57
168
6
11
40
#ACC2020
still going as planned
We are also working with the McCormick Place Convention Center, the city of Chicago and others to coordinate additional health and safety measures on site in Chicago”
ACC.20/WCC Coronavirus (COVID-19) Update
7
8
39
Such an honor to meet the one and only
@SABOURETCardio
in person
#eas2022
lots of discussion for transatlantic collaboration especially focusing on
#CAC
use in Europe..need partners and stronger collaboration
@miguelcainzos23
@MaBMortensen
@DrMarthaGulati
@rauldsf_santos
@pabeda1
1
2
40
🔍🧠
@rblument1
pioneer of
#ModernPreventiveCardiology
imparting invaluable wisdom
🎯 Start with precise risk assessment
💡 CAC is the clear path forward
👁️🗨️
#SeeDiseaseTreatDisease
Wholeheartedly concur!
@Heart_SCCT
0
14
40